key: cord-0828939-zppiy8hb
authors: Yuan, Xin‐hui; Li, Yu‐mei; Shen, Yi‐yi; Yang, Jin; Jin, Yu
title: Clinical and Th1/Th2 immune response features of hospitalized children with human rhinovirus infection
date: 2019-09-18
journal: J Med Virol
DOI: 10.1002/jmv.25587
sha: 1a7afdb09d0308a41d40e5a4e72268a361519dfa
doc_id: 828939
cord_uid: zppiy8hb

This study aimed to assess the clinical characteristics and T‐helper 1 (Th1)/Th2 profile of human rhinovirus (HRV) infection in children with bronchiolitis and pneumonia, compared with the respiratory syncytial virus (RSV). In September 2013 to August 2014, 335 nasopharyngeal aspirates from children below 14 with bronchiolitis and pneumonia were screened for HRV and 13 other respiratory viruses by PCR or reverse transcription PCR. Interferon (IFN)‐γ, interleukin (IL)‐2, IL‐4, IL‐6, IL‐10, and tumor necrosis factor (TNF)‐α were detected by multiplex enzyme‐linked immunosorbent assay. HRVs were found in 66 cases (19.7%), including 35 bronchiolitis and 31 pneumonia cases. Compared with the RSV alone group, children with pneumonia had more frequent wheezing episodes in HRV (P (a) = .001) and HRV + non‐RSV (P (b) = .002) groups, and fever in the HRV (P (f) = .004) and HRV + RSV (P (g) = .005) groups. Among patients with bronchiolitis, cases with HRV alone were more likely to present in winter than those with RSV alone (P (i) = .010) and HRV + non‐RSV (P (j) = .014), and less numerous in summer compared with HRV + non‐RSV (P (h) = .005). Children with HRV alone were more susceptible to have a history of eczema than RSV alone among bronchiolitis (P (c) < .001) and pneumonia (P (e) = .033) cases. HRV bronchiolitis cases had increased IL‐4/IFN‐γ and decreased TNF‐α/IL‐10 ratios, compared with HRV pneumonia counterparts. HRV is a major non‐RSV pathogen causing hospitalization in children with bronchiolitis and pneumonia and induces an imbalanced Th1/Th2 response in bronchiolitis. Compared with RSV infection, HRV bronchiolitis and pneumonia differ significantly regarding wheezing episodes, susceptibility to eczema, fever occurrence, and seasonal prevalence.

HRV belongs to the Enterovirus genus (Picornaviridae family) and is genetically diverse. Based on phylogenetic sequence criteria, HRVs are classified into three species, including HRV-A, HRV-bronchiolitis (HRV-B), and HRV-C, 8 and more than 150 distinct serotypes according to surface proteins. 9 The prevalence and disease severity of bronchiolitis and pneumonia induced by HRV-A and HRV-C are higher than those involving HRV-B. A previous study demonstrated that HRV-B exhibits lower and slower replication and less cytopathic effects. 10 Exposure of airway epithelial cells to HRV leads to the release of proinflammatory products, which are related to pathogenic mechanisms and help initiate antiviral responses. The T-helper 1 (Th1)/Th2 imbalance plays an important role in immune responses to viral infections and asthma development. Previous findings indicate that rhinovirus or RSV bronchiolitis early in life is associated with an increased risk of asthma. 11, 12 Wheezing induced by HRV in young children is an important predictive factor of recurrent wheezing. 13, 14 Therefore, understanding clinical and associated immunological features of HRV would help prevent and treat HRV respiratory diseases. In this study, we aimed to assess the epidemiological and clinical characteristics of HRV infection, determining the Th1-and Th2-related cytokine profiles of HRV infection in children with bronchiolitis and pneumonia. showing no underlying diseases, including asthma, congenital heart disease, immunodeficiency disease, and bronchopulmonary dysplasia.

Pneumonia was defined as acute respiratory infection with pulmonary infiltrates on chest X-ray diagnosed by a radiologist. Bronchiolitis was diagnosed by the presence of wheezing combined with tachypnea, atelectasis, or peribronchial thickening on chest X-ray in children aged ≤2 years. Ten healthy children without a history of recurrent wheezing and no respiratory infection symptoms within 2 weeks in the children's health clinics were recruited as a control group for cytokine detection. Demographic data, clinical findings, and medical test results were collected with standardized forms.

Informed consent was obtained from the parents of enrolled children.

The study protocol was approved by the hospital's ethics committee.

Nasopharyngeal aspirates (NPAs) were collected from inpatients the day of admission alongside healthy children in the children's health clinics. Then, samples were transferred into virus transport medium and stored at −80℃ until further processing.

DNA and RNA were extracted from 0.2 mL of each NPA with QIAamp viral DNA Minikit and QIAamp viral RNA Minikit (Qiagen, Nanjing, China), respectively. The primers used to amplify a 549-base pair fragment of HRV (forward: 5′-GGGACCAACTACTTTGG GTGTCCGTGT-3′ and reverse: 5′-GCATCIGGYARYTTCCACCACC ANCC-3′) were described previously. 15 

Next, NPA specimens from patients infected with either HRV or RSV alone and healthy children were selected for cytokine detection. There 

Statistical analysis was performed with SPSS, version 19.0. Demographic and clinical parameters were compared among the HRV alone, RSV alone, HRV + RSV, and HRV + non-RSV groups. The χ 2 test was applied for categorical variables. The Student t test or nonparametric the Kruskal-Wallis test was used for continuous variables, as appropriate. Comparisons of cytokines concentration between the groups were performed using the nonparametric the Mann-Whitney U test.

Two-tailed P < .05 was considered statistically significant.

Of the 335 inpatients, there were 257 males, indicating a malefemale ratio of 3 were similar (P > .05). However, RSV was more likely associated with bronchiolitis than pneumonia (P = .043).

There were 33 (50.0%) coinfection cases involving HRV, including 18 RSV, 4 ADV, 2 PIV3, 2 hMPV, 3 ADV + PIV3, 1 ADV + PIV1, 2 RSV + ADV, and 1 PIV4 + HBOV cases. Next, 335 LRTIs cases were assessed by sputum bacteria culture. A total of 9.1% (6/66) of HRV cases were coinfected with bacteria, including three with Haemophilus influenza, two with Klebsiella pneumonia, and one with Streptococcus pneumonia.

The prevalence cycles of HRV and RSV associated bronchiolitis and pneumonia are presented in Figure 

Since HRV coinfects with other viruses frequently, with RSV being the most common copathogen, we evaluated the clinical characteristics of children with HRV and RSV single infections, as well as HRV cases coinfected with or without RSV (Table 1) . Mean ages and age distributions of patients with bronchiolitis and pneumonia were similar among various viral groups (P > .05). Furthermore, children with HRV infection had more frequent wheezing episodes compared with those with RSV (P a = .001) and HRV + non-RSV (P b = .002) infections among pneumonia cases, but comparable with other groups among bronchiolitis cases (P = .138). Children with a history of eczema, who did not present during the current illness were more likely to be infected with HRV than RSV (P c = .000) and HRV + non-RSV (P d = .003) among bronchiolitis cases. Similar results were found in children with pneumonia (P e = .033). Median length of hospital stay (LOS) values in HRV alone cases with bronchiolitis and pneumonia, respectively, were identical, that is, 8.5 days, and similar with those of other groups. LOS more than seven was not different in bronchiolitis and pneumonia cases among HRV alone and other viral groups (P > .05). No significant differences were found in terms of supplemental oxygen, tachypnea, and white blood count among the HRV and the other three groups (P > .05). Children with pneumonia in the HRV group were more likely to have fewer than those of the RSV (P f = .004) and HRV + RSV (P g = .005) groups. HRV associated pneumonia was less likely to occur in summer months than HRV + non-RSV (P h = .005), while HRV associated bronchiolitis was more likely to occur in winter months than RSV (P i = .01) and HRV + non-RSV (P j = .014). Age (mean ± SD) 8.5 ± 11.6 6.2 ± 6.5 13.6 ± 21. In the present study, HRV was found in 19.5% of children with lower respiratory infection (LRIs), and detection rates were similar in bronchiolitis (20.5%) and pneumonia (18.9%) cases. The results revealed that HRV is not only a major viral etiology of pneumonia but also the second leading cause of bronchiolitis after RSV, corroborating previous studies. 2, 3, 17, 18 Unlike RSV, HRV showed similar incidence rates between the bronchiolitis and pneumonia cases. Many prospective long-term studies have shown that RSV-induced bronchiolitis is associated with later development of asthma. 19, 20 However, a recent cohort study suggested that infants wheezing as a result of HRV infection may be at greater risk of subsequent asthma compared with RSV, PIV, and influenza virus-infected counterparts. 21 Therefore, HRV is not only a cause of lower respiratory tract illness but also represents a significant pathogen Previous data have revealed that HRVs circulate year-round and prevail in fall and winter. 18, 24, 25 The seasonal distributions of HRVs vary F I G U R E 2 (A and B). Elevated cytokine levels in nasopharyngeal aspirates from HRV and RSV induced bronchiolitis or pneumonia compared with controls. HRV, human rhinovirus; RSV, respiratory syncytial virus according to the geographic area as well as the resulting disease. This study showed that HRV-induced pneumonia and bronchiolitis were prevalent in winter and spring. HRV-C incidence peaked in winter and late spring months, while HRV-A was detected mainly during the autumn and spring months, in general agreement with findings by others. 5, 9 Previous studies reported that the seasonal distributions of HRVs are consistent with asthma occurrence in hospitalized children, 26 and indicated that HRV infection is more likely to cause severe illness in winter than other seasons. 23 This study demonstrated that the epidemic seasons of HRV were predominantly in winter and spring months, which accorded with the episodes of most bronchiolitis and pneumonia cases.

Therefore, rhinovirus is an important pathogen causing bronchiolitis and pneumonia in children in winter and spring.

In the present study, mean ages and age distributions were similar among the HRV alone and RSV alone groups, which is consistent with previous studies 27, 28 , but in contrast with the finding that patients with HRV-induced lower respiratory tract infection (LRTI) tend to be older than RSV cases. 29 This may be related to different study designs. Patients with HRV single infection presented more often a history of eczema than the RSV and HRV + non-RSV groups, which accorded with findings in a multicenter study. 6 Furthermore, the COAST study evaluated the relationship between HRV illness and allergic sensitization and showed that allergic sensitization may precede rhinovirus associated wheezing but not RSV infection. 30 39 Moreover, a recent study showed that the majority of HRV-infected infants display a high Th2 response, while the majority of RSV-infected infants show a Type-1 response. 40 In the current study, Th2/Th1 ratios were higher in HRV and RSV associated F I G U R E 3 IL-4/IFN-γ, IL-6/IL-2, and TNF-a/IL-10 ratios in nasopharyngeal aspirates from HRV and RSV induced bronchiolitis or pneumonia and the controls. Medians are represented by horizontal bars. Note: Data in Figures 2 and 3 were analyzed by the Mann-Whitney U test or the Kruskal-Wallis test; *P ≤ .05; **P < .01; ***P < .001. RSV-B: bronchiolitis cases with RSV alone, RSV-P: pneumonia cases with RSV alone, HRV-B: bronchiolitis cases with HRV alone, HRV-P: pneumonia cases with HRV alone. HRV-B, human rhinovirus bronchiolitis; IL, interleukin; RSV-B, respiratory syncytial virus bronchiolitis; RSV-P: respiratory syncytial virus pneumonia; TNF, tumor necrosis factor bronchiolitis compared with pneumonia and control cases, reflected by increased IL-4/IFN-γ and decreased TNF-α/IL-10 ratios, which suggested that excessive Th2 or deficient Th1 response may be associated with the pathogenesis of HRV bronchiolitis. The reason why IL-6/IL-2 ratios were not significantly different between bronchiolitis and pneumonia cases in both HRV and RSV groups is difficult to explain. However, it may be explained by that IL-6 represents a potent mediator of cellular communication, is crucial for the regulation of innate and adaptive inflammatory responses, 41 and is positively associated with illness severity in RSV and HRV associated lower respiratory tract infection. 42, 43 Taken together, an imbalanced Th1/Th2 response plays an important role in the pathogenesis of HRV bronchiolitis and may be one of the reasons for asthma development.

This study has potential limitations. First, we did not test concurrent healthy controls to determine the prevalence of asymptomatic rhinovirus shedding. Another limitation is the low number of subjects in the virus groups and cytokine detection assays since the cases recruited had single virus infections and similar backgrounds.

In conclusion, this study showed that HRV is the second most 

Virological and serological analysis of rhinovirus infections during the first two years of life in a cohort of children

Spectrum of respiratory viruses in children with communityacquired pneumonia

The role of rhinovirus in children hospitalized for acute respiratory disease

Viral bronchiolitis in children

Seasonal variations of respiratory viruses and etiology of human rhinovirus infection in children

Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis

Hospital length-of-stay is associated with rhinovirus etiology of bronchiolitis

MassTag polymerase-chainreaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during

Molecular epidemiology of rhinoviruses in Cyprus over three consecutive seasons

Effects of rhinovirus species on viral replication and cytokine production

Rhinovirus wheezing illness and genetic risk of childhood-onset asthma

Pulmonary epithelial barrier and immunological functions at birth and in early life -key determinants of the development of asthma? A description of the protocol for the breathing together study

Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema

Rhinovirus illnesses during infancy predict subsequent childhood wheezing

Prevalence and clinical characterization of a newly identified human rhinovirus C species in children with acute respiratory tract infections

Aetiology of influenza-like illness in adults includes parainfluenzavirus type 4

Comparison of human metapneumovirus, respiratory syncytial virus and rhinovirus respiratory tract infections in young children admitted to hospital

Human rhinovirus infections in hospitalized children: clinical, epidemiological, and virological features

Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study

Adolescent asthma after rhinovirus and respiratory syncytial virus bronchiolitis

The ABCs of rhinoviruses, wheezing, and asthma

Molecular epidemiology of human rhinovirus infections in the pediatric emergency department

Human rhinovirus species and season of infection determine illness severity

Respiratory viral infections during the 2009-2010 winter season in Central England, UK: incidence and patterns of multiple virus coinfections

Human rhinovirus C: age, season, and lower respiratory illness over the past 3 decades

Rhinovirus-associated hospitalizations in young children

Equal virulence of rhinovirus and respiratory syncytial virus in infants hospitalized for lower respiratory tract infection

Viral aetiology of bronchiolitis in hospitalised children in Qatar

Children hospitalized with rhinovirus bronchiolitis have asthma-like characteristics

Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life

Rhinovirus bronchiolitis and recurrent wheezing: 1-year follow-up

Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. American journal of respiratory and critical care medicine

Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study

Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing

Different cytokine profile and eosinophil activation are involved in rhinovirus-and RS virusinduced acute exacerbation of childhood wheezing

Comparison of cytokine expression profiles in infants with a rhinovirus induced lower respiratory tract infection with or without wheezing: a comparison with respiratory syncytial virus

How does rhinovirus cause the common cold cough?

Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production

Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis

Analysis of the immune response in infants hospitalized with viral bronchiolitis shows different Th1/Th2 profiles associated with respiratory syncytial virus and human rhinovirus

Directing transition from innate to acquired immunity: defining a role for IL-6

Novel inflammatory markers, clinical risk factors, and virus type associated with severe respiratory syncytial virus infection

Proinflammatory cytokines in nasopharyngeal aspirate from hospitalized children with respiratory syncytial virus infection with or without rhinovirus bronchiolitis, and use of the cytokines as predictors of illness severity

The authors declare that there are no conflict of interests.

http://orcid.org/0000-0002-4126-6724